Kestra Medical Technologies (KMTS) Preferred Stock Liabilities (2024 - 2025)

Kestra Medical Technologies' (KMTS) quarterly Preferred Stock Liabilities came in at $280.5 million in Q1 2025, up 58.38% on a QoQ basis from $177.1 million in Q2 2024.

Kestra Medical Technologies (KMTS) Preferred Stock Liabilities (2024 - 2025) Analysis & Trends

Kestra Medical Technologies (KMTS) has 2 years of Preferred Stock Liabilities data on file, last reported at $280.5 million in Q1 2025.

  • On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $280.5 million in Q1 2025; TTM through Jan 2025 was $280.5 million, a N/A change from a year earlier, with the FY2024 full-year figure at $177.1 million, changed N/A from the prior year.
  • Preferred Stock Liabilities for Q1 2025 stood at $280.5 million, up from $177.1 million in the prior quarter.
  • Over the last five years, Preferred Stock Liabilities for KMTS reached as high as $280.5 million in Q1 2025 and fell as low as $177.1 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn -
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn -
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn -
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn -
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn -
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn -
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn -
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn -
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn -
10 Kestra Medical Technologies 1.17 Bn 809.84 Mn 15.68 Mn -

Historic Data

Download Data
DateValue
Jan 31, 2025 280.51 Mn
Apr 30, 2024 177.11 Mn